Chronic Mesenteric Ischemia
Executive Summary
Chronic mesenteric ischemia (CMI), also known as intestinal angina, is a condition caused by a reduction in intestinal blood flow, typically resulting from episodic or continuous hypoperfusion. The primary cause is atherosclerosis, which leads to significant stenosis or occlusion in at least two of the three main mesenteric arteries (celiac, superior mesenteric, and inferior mesenteric). While significant mesenteric artery stenosis is found in up to 18% of asymptomatic individuals over 65 due to extensive collateral circulation, the clinical manifestation of CMI is rare.
Symptomatic patients are typically over 60, often female, and have a history of smoking and other cardiovascular diseases. The classic clinical presentation includes postprandial abdominal pain (dull, crampy pain starting within an hour of eating), an adapted eating pattern (food aversion to avoid pain), and significant weight loss, which is present in approximately 80% of cases. The average delay from symptom onset to diagnosis is over 10 months.
Diagnosis requires a high index of clinical suspicion, supported by vascular imaging. Computed tomographic (CT) angiography is the recommended initial imaging study, demonstrating high-grade stenosis in multiple vessels with over 90% sensitivity and specificity. Management of symptomatic CMI is centered on revascularization to relieve symptoms, prevent bowel infarction, and reverse weight loss. The two primary approaches are endovascular stenting and open surgical bypass. Endovascular revascularization is recommended as the initial approach for most patients due to lower perioperative morbidity and shorter hospital stays. However, open surgery is more durable with lower restenosis rates and may be preferred for younger, healthier patients with a long life expectancy. Long-term survival is similar regardless of the revascularization method, with cardiac disease being the most common cause of late mortality.
I. Overview and Etiology
Definition
Chronic mesenteric ischemia (CMI) is a vascular disorder characterized by inadequate blood supply to the small intestine. This hypoperfusion is typically episodic or continuous and arises from stenosis (narrowing) or occlusion (blockage) of the mesenteric arteries. The condition is most often diagnosed in patients with disease affecting multiple mesenteric vessels.
Primary Cause: Atherosclerosis
The vast majority of CMI cases are caused by atherosclerosis of the celiac or superior mesenteric arteries (SMA).
Prevalence: While clinical symptoms are rare, underlying atherosclerotic disease is relatively common in the older population.
Up to 18% of individuals over 65 have significant stenosis of the celiac or superior mesenteric artery without any known prior symptoms.
A population-based study of 870 patients over 65 found a similar prevalence of 17.5%.
Asymptomatic Nature: Most patients with atherosclerotic mesenteric disease do not exhibit symptoms because of an extensive network of collateral vessels that can compensate for reduced flow. A study of 270 patients with occlusive disease in one or more splanchnic vessels found that 61 (60%) were asymptomatic.
Other Associated Causes
Though rare, several other conditions can cause CMI:
Iatrogenic Causes: Inadvertent coverage or obstruction of visceral vessels during endovascular aortic aneurysm repair.
Vascular Diseases: Fibromuscular dysplasia, aortic or mesenteric artery dissection, and vasculitis (such as polyarteritis nodosa and Takayasu disease).
Fibrosis: Retroperitoneal fibrosis.
II. Clinical Presentation and Patient Profile
The Symptomatic Patient
Patients who manifest symptoms of CMI typically fit a specific demographic and clinical profile:
Age: Usually over 60 years old.
Gender: Three times more likely to be female than male.
Risk Factors: A majority of patients have a history of smoking (58%), and approximately half have a history of coronary artery disease, cerebrovascular disease, or lower extremity peripheral artery disease.
Key Symptomatic Manifestations
The clinical presentation of CMI is defined by a distinct set of symptoms related to eating and its physiological demands.
Intestinal Angina: This is the hallmark symptom, characterized by recurrent abdominal pain after eating.
Description: The pain is classically described as dull, crampy, and located in the epigastric region.
Timing: It typically begins within the first hour after a meal and subsides over the subsequent one to two hours.
Triggers: The severity of the pain can be variable and may be exacerbated by larger meals or those with high-fat content.
Adapted Eating Pattern and Weight Loss: The association of pain with eating leads to a fear of food (food aversion).
Patients consciously or subconsciously reduce their food intake to avoid triggering the pain, leading to an "adapted eating pattern."
This results in significant weight loss, which is a key clinical finding in approximately 80% of symptomatic patients.
In a survey of 270 patients, the probability of CMI was 60% if all four classic symptoms (postprandial pain, chronic diarrhea, adapted eating pattern, weight loss) were present, compared to only 13% if none were present.
Acute-on-Chronic Mesenteric Ischemia: A dangerous progression where a thrombus forms within a narrowed mesenteric artery segment.
This leads to acute, severe abdominal pain and carries a much higher morbidity and mortality rate (perioperative mortality can reach 50%) compared with patients experiencing only chronic symptoms.
Intestinal Dysbiosis: Patients with CMI have been shown to have a loss of alpha diversity within their intestinal microbiome, a condition that may resolve following successful revascularization.
III. Diagnostic Strategy
Clinical Suspicion and Diagnostic Delay
A high index of suspicion is critical for a timely diagnosis. The average delay from the onset of symptoms to diagnosis or treatment is 10.7 months, often because the symptoms are nonspecific. A presumptive diagnosis is made when a patient presents with the classic symptoms (postprandial pain, adapted eating pattern, weight loss) and imaging confirms high-grade stenosis or occlusion in two or more mesenteric vessels.
Vascular Imaging Modalities
Demonstration of stenosis in the major mesenteric vessels is a requirement for diagnosis.
Functional Studies
The clinical utility of functional studies like tonometry, spectroscopic oximetry, and MR flow measurement has been suggested but is not yet established for the routine diagnosis of CMI.
IV. Management and Treatment Approaches
Medical and Nutritional Management
Asymptomatic Patients: For patients with incidental findings of mesenteric occlusive disease, management focuses on risk factor modification for atherosclerosis. This includes tobacco cessation, antiplatelet therapy (aspirin), and management of hypertension and hypercholesterolemia.
Symptomatic Patients: These patients often present with significant weight loss and malnutrition (BMI <18.5). While nutritional status should be evaluated, revascularization should not be delayed to provide nutritional repletion.
Indications for Revascularization
The primary indication for revascularization is the presence of symptoms. The goals of intervention are to:
Relieve abdominal pain and weight loss.
Prevent bowel infarction and progression to acute ischemia.
Reverse nutritional depletion. Prophylactic revascularization in asymptomatic patients has little established role.
Revascularization Techniques
Treatment options include endovascular, open surgical, or hybrid approaches. The celiac and superior mesenteric arteries are the primary targets for revascularization.
Endovascular Revascularization: This is the most common initial approach and includes:
Percutaneous Angioplasty and Stenting: A stent (often a covered stent) is placed via catheter to restore flow. This is the preferred technique.
Retrograde Open Mesenteric Stenting (ROMS): A hybrid technique where the mesenteric artery is accessed via a small laparotomy to place a stent in a retrograde fashion.
Open Surgical Revascularization: Traditional surgical options include:
Open Mesenteric Bypass: Creating a bypass graft from the aorta to the mesenteric artery.
Transaortic Endarterectomy: Surgical removal of plaque from the inside of the artery.
V. Comparative Analysis of Revascularization
Treatment Recommendations and Patient Selection
The decision between endovascular and open surgery is based on patient factors, life expectancy, and anatomical considerations.
Initial Approach: The Society for Vascular Surgery recommends an endovascular-first approach for most patients with CMI. This is based on data showing improved perioperative outcomes with similar long-term survival rates.
Open Surgery Preference: Open revascularization may be the best initial approach for:
Younger, healthier patients with a longer life expectancy, as open repairs are more durable.
Patients with anatomy unsuitable for an endovascular approach.
Patients who have previously failed endovascular interventions.
Comparative Outcome Data
A review of studies from 2000 to 2009 involving over 1000 patients provided the following comparative data:
A later meta-analysis confirmed that the endovascular approach is associated with lower perioperative complications, shorter hospital stays, and lower costs, but with a slightly higher rate of reinterventions.
Cost-Effectiveness
While five-year costs are greater for endovascular revascularization (due to higher reintervention rates), it provides higher levels of quality-adjusted life years, suggesting it is a more effective overall strategy.
VI. Outcomes and Long-Term Follow-Up
Mortality
Perioperative Mortality: Ranges from 0 to 16% for elective CMI procedures but can be as high as 50% for patients presenting with acute-on-chronic mesenteric ischemia.
Long-Term Survival: Survival is similar regardless of the revascularization technique used. Late deaths are less likely to be related to mesenteric ischemia.
Causes of Late Mortality: A review of 144 patients found that the most common cause of death during follow-up was cardiac disease (35%), followed by cancer (15%), pulmonary complications (13%), and recurrent mesenteric ischemia (11%).
Recurrence and Reintervention Rates
Long-term success is limited by recurrent stenosis, which is significantly more common after endovascular procedures.
Recurrence after Endovascular Revascularization:
Recurrent stenosis occurs in 5 to 15% of patients.
Symptomatic recurrence often happens within the first year.
A systematic review found a restenosis rate of 34% in patients treated for CMI.
Midterm freedom from reintervention rates were 87% at one year and 71% at three years.
Recurrence after Open Surgical Revascularization:
Primary graft patency rates at five years range from 57% to 69%.
A systematic review found a restenosis rate of only 7%.
Long-term symptom relief is achieved in 80% to 90% of patients.
Routine follow-up with imaging (e.g., duplex ultrasonography) is crucial to detect recurrent stenosis before symptoms reappear. Recurrent symptoms can often be managed with repeat endovascular intervention.
